Spots Global Cancer Trial Database for sentinel node biopsy
Every month we try and update this database with for sentinel node biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient | NCT01521000 | Breast Cancer | Garment Sleeve | 18 Years - | Main Line Health | |
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative | NCT05774483 | Mouth Neoplasms | Sentinel Node B... Limited Electiv... | 18 Years - 80 Years | Tata Memorial Hospital | |
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy | NCT04109079 | Breast Cancer Sentinel Lymph ... Neoplasm, Breas... | Axillary lymph ... Axillary radiot... Breast or chest... | 18 Years - | University Hospitals of Derby and Burton NHS Foundation Trust | |
Infrared Lymphangiography as a Method of Sentinel Node Identification | NCT02057393 | Melanoma Sentinel Node | Indocyanine gre... Technetium99 Methylene blue | 18 Years - | Milton S. Hershey Medical Center | |
Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD) | NCT03102307 | Early Stage Bre... | Not suitable fo... Suitable for TA... | 18 Years - | Kliniken Essen-Mitte | |
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation | NCT00575744 | Breast Cancer | Sentinel Node B... | 18 Years - | University of Arkansas | |
Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response | NCT05371860 | Breast Cancer HER2-positive B... | Omit breast rad... | 40 Years - | Cedars-Sinai Medical Center | |
Sienna+® Injection Time Study 4 Arms | NCT02612870 | Breast Neoplasm... | Sienna+ retro Sienna+ peri Sienna+ retro 4... Sienna+ peri 4-... Technetium 1 | 18 Years - 85 Years | Kantonsspital Baden | |
Validation of Ferromagnetic Tracer in Melanoma Sentinel Node | NCT03449615 | Melanoma Stage Sentinel Lymph ... | 18 Years - | Sociedad Española de Oncología Quirúrgica | ||
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy | NCT04436809 | Breast Neoplasm... | Sentinel Node B... Axillary Dissec... | - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
Fluorescence Surgery for Sentinel Node Identification in Melanoma | NCT02142244 | Melanoma Lymph Node Meta... | Near infra red ... Indocyanine gre... Intraoperative ... | 18 Years - | Barretos Cancer Hospital | |
Sentinel Node Biopsy in Endometrial Cancer | NCT04073706 | Endometrial Can... Sentinel Lymph ... Surgery | TH BSO with SNB... TH BSO without ... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience | NCT05950737 | Oral Cavity Squ... | Sentinel node b... | 18 Years - 75 Years | Tata Memorial Hospital | |
Sentinel Node Extended in Squamous Cell Vulvar Cancer | NCT04147780 | Vulva Cancer Sentinel Lymph ... | Sentinel node b... | 18 Years - | Karolinska University Hospital | |
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. | NCT00315159 | Vulvar Cancer | Sentinel Node B... | 18 Years - | Women and Infants Hospital of Rhode Island | |
Sentinel Node Extended in Squamous Cell Vulvar Cancer | NCT04147780 | Vulva Cancer Sentinel Lymph ... | Sentinel node b... | 18 Years - | Karolinska University Hospital | |
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy | NCT06212440 | Sentinel Lymph ... Neoadjuvant The... Breast Neoplasm | Identification ... | 20 Years - | National Cancer Center, Korea | |
Robot-assisted Approach to Cervical Cancer | NCT03719547 | Cervical Cancer | Abdominal radic... Robot-assisted ... Sentinel lymph ... | 18 Years - | Karolinska Institutet | |
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation | NCT00575744 | Breast Cancer | Sentinel Node B... | 18 Years - | University of Arkansas | |
Sienna+® Injection Time Study 4 Arms | NCT02612870 | Breast Neoplasm... | Sienna+ retro Sienna+ peri Sienna+ retro 4... Sienna+ peri 4-... Technetium 1 | 18 Years - 85 Years | Kantonsspital Baden | |
Fluorescence Surgery for Sentinel Node Identification in Melanoma | NCT02142244 | Melanoma Lymph Node Meta... | Near infra red ... Indocyanine gre... Intraoperative ... | 18 Years - | Barretos Cancer Hospital | |
Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis | NCT02049632 | Breast Cancer | Omission of axi... | 18 Years - | Karolinska Institutet | |
Sentinel Node Biopsy in Endometrial Cancer | NCT04073706 | Endometrial Can... Sentinel Lymph ... Surgery | TH BSO with SNB... TH BSO without ... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. | NCT00315159 | Vulvar Cancer | Sentinel Node B... | 18 Years - | Women and Infants Hospital of Rhode Island | |
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy | NCT06212440 | Sentinel Lymph ... Neoadjuvant The... Breast Neoplasm | Identification ... | 20 Years - | National Cancer Center, Korea | |
Infrared Lymphangiography as a Method of Sentinel Node Identification | NCT02057393 | Melanoma Sentinel Node | Indocyanine gre... Technetium99 Methylene blue | 18 Years - | Milton S. Hershey Medical Center | |
A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma | NCT05418972 | Stage II Melano... | Relatlimab and ... | 18 Years - | Melanoma Institute Australia |